Acumen Pharmaceuticals, Inc.
ABOS
$1.98
$0.052.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 126.61M | 143.37M | 149.15M | 171.56M | 200.34M |
| Total Receivables | 718.00K | 562.00K | 707.00K | 628.00K | 319.00K |
| Inventory | -- | -- | -- | 159.00K | 143.00K |
| Prepaid Expenses | 703.00K | 169.00K | 481.00K | 858.00K | 1.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.12M | 4.30M | 4.61M | 5.10M | 5.82M |
| Total Current Assets | 132.15M | 148.40M | 154.95M | 178.31M | 207.63M |
|
|
|||||
| Total Current Assets | 132.15M | 148.40M | 154.95M | 178.31M | 207.63M |
| Net Property, Plant & Equipment | 288.00K | 335.00K | 373.00K | 339.00K | 385.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 337.00K | 361.00K | 363.00K | 379.00K | 406.00K |
| Total Assets | 142.22M | 171.90M | 204.48M | 238.99M | 266.98M |
|
|
|||||
| Total Accounts Payable | 682.00K | 2.10M | 1.06M | 5.65M | 2.34M |
| Total Accrued Expenses | 17.18M | 22.46M | 17.70M | 21.60M | 17.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.74M | 142.00K | 138.00K | 133.00K | 129.00K |
| Total Finance Division Other Current Liabilities | 352.00K | 161.00K | 418.00K | 230.00K | 201.00K |
| Total Other Current Liabilities | 352.00K | 161.00K | 418.00K | 230.00K | 201.00K |
| Total Current Liabilities | 21.96M | 24.86M | 19.32M | 27.61M | 19.91M |
|
|
|||||
| Total Current Liabilities | 21.96M | 24.86M | 19.32M | 27.61M | 19.91M |
| Long-Term Debt | 27.05M | 29.88M | 29.53M | 29.42M | 29.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 39.00K | 77.00K | 114.00K | 150.00K | 185.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 49.05M | 54.82M | 48.96M | 57.18M | 49.77M |
|
|
|||||
| Common Stock & APIC | 514.39M | 511.93M | 509.43M | 506.99M | 504.66M |
| Retained Earnings | -421.32M | -394.87M | -353.92M | -325.13M | -287.97M |
| Treasury Stock & Other | 109.00K | 23.00K | 15.00K | -48.00K | 518.00K |
| Total Common Equity | 93.17M | 117.08M | 155.52M | 181.82M | 217.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 93.17M | 117.08M | 155.52M | 181.82M | 217.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 93.17M | 117.08M | 155.52M | 181.82M | 217.20M |
|
|
|||||